Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001071386 | SCV001236689 | pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2022-12-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FAS protein in which other variant(s) (p.L294*) have been determined to be pathogenic (PMID: 10090885, 21490157, 23407489). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Experimental studies have shown that this premature translational stop signal affects FAS function (PMID: 7540117). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 16501). This variant is also known as C1011T (Glu257*). This premature translational stop signal has been observed in individual(s) with autoimmune lymphoproliferative syndrome (PMID: 7540117). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln273*) in the FAS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 63 amino acid(s) of the FAS protein. |
OMIM | RCV000017965 | SCV000038244 | pathogenic | Autoimmune lymphoproliferative syndrome, type 1a | 1995-06-16 | no assertion criteria provided | literature only |